NewsBenzingaNovavax eleva su previsión de ventas para el ejercicio fiscal 2026 de $235.000 millones-$275.000 millones a $385.000 millones-$415.000 millones frente a una estimación de $380.285 millones Novavax eleva su previsión de ventas para el ejercicio fiscal 2026 de $235.000 millones-$275.000 millones a $385.000 millones-$415.000 millones frente a una estimación de $380.285 millones Benzinga 2026.11.05 13:01 (GMT+0) Open on Benzinga Other news Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory NVIDIA Expands Vera CPU Racks for Scientific Computing Are Wall Street Analysts Predicting Lowe's Stock Will Climb or Sink? A whale accumulates 238,400 LINK from Binance in two days, worth about $2.2 million Google Warns ‘Era of Autonomous Attacks Has Arrived’ as United Airlines, JPMorgan Chase and Microsoft Grapple With Outages
Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips
Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory
Google Warns ‘Era of Autonomous Attacks Has Arrived’ as United Airlines, JPMorgan Chase and Microsoft Grapple With Outages